Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 10 reviews

530%
440%
330%
20%
10%
Ask AI

Questions about Biointaxis

Based on 10 reviews, listing data and website checks · updated 5 days ago

What is Biointaxis?

Biointaxis is an academic spin-off company created from the Health Sciences Research Institute Germans Trias i Pujol (IGTP) in Badalona, Barcelona. The team is led by Dr. Matilla and Dr. Sánchez, who are pioneers in identifying ataxia genes and researching neurodegenerative disorders. They focus on developing life-changing treatments for rare genetic diseases such as Friedreich’s ataxia.

What specific product or service does Biointaxis offer?

The company develops a gene therapy product to re-establish the function of a defective protein in Friedreich ataxia patients. They create significant value at the early stages of product development, including R&D, pre-clinical proof-of-concept and regulatory work, and early clinical trials like Phase I/II.

How does Biointaxis plan to bring its treatment to market?

Biointaxis aims to license the production and distribution rights to Pharma partners equipped with a reputation. They are looking for partners who can take their gene therapy treatment for Friedreich's ataxia further in development and commercialization.

Who are the key people leading Biointaxis?

The management and advisory board includes Antoni Matilla Dueñas Ph.D. as CEO, Ivelisse Sánchez Ph.D. as CSO, Jaime Melendo as Board Member, Daniel Pérez as Chief Financial Officer, Luis Ruiz Avila Ph.D. as Senior Business Advisor, and Miguel Chillón Ph.D. as Scientific Advisor.

What funding or grants has Biointaxis received?

The company received funding from the Ministerio de Ciencia e Innovación under the Programa Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 for their project on developing an innovative gene therapy drug for ataxia.

What do reviewers say they like about Biointaxis?

Some reviewers on Trustburn praise Biointaxis for its professionalism, dedication, and ability to provide innovative solutions that exceed expectations. They also highlight the team's knowledge, responsiveness, and reliability in tailoring solutions to specific needs.

What is the current rating and review history for Biointaxis?

As of the latest reviews, Biointaxis has a Trustburn rating of 4 out of 5 stars from 10 reviews. The most recent review was posted on November 24, 2023, and the oldest on this list was posted on December 12, 2022.

What are the core values of Biointaxis?

The company's core values include being patient-centric, acting beyond hope, operating as a business for good, maintaining accountability, and emphasizing team-up. They also value science that is involved and committed.

What disease does Biointaxis primarily target?

Biointaxis focuses on neurodegenerative rare diseases, specifically targeting Friedreich’s ataxia, which typically affects teenagers and young adults. Their research has shown efficacy in re-establishing neurological functions in mice models of the disease.

At what stage of development does Biointaxis operate?

The company operates at the early stages of product development, including R&D, pre-clinical phases, and early clinical trials. They aim to deliver top-notch services and streamline operations for their partners.

How experienced are the team members at Biointaxis?

The team includes experts with significant experience, such as Jaime Melendo with 32 years in Pharma and Biotech, and Miguel Chillón Ph.D., an ICREA Professor with 23 years in gene therapy strategies using AAV viral vectors.

How long has Biointaxis been in operation?

Biointaxis was recently created from the IGTP, making it a relatively new entity in the biotech sector. The company is still in the process of developing its gene therapy treatment for Friedreich's ataxia.

What is the mission of Biointaxis?

The company's mission is to defeat rare diseases and restore patients' health by developing life-changing treatments. They aim to provide excellent services and solutions for companies looking for innovative approaches.

What makes Biointaxis unique compared to other biotech companies?

Biointaxis is an academic spin-off that benefits from extensive know-how in identifying genes and mechanisms underlying neurodegenerative disorders. They are committed to creating significant value at the early stages of product development.

How can I contact Biointaxis?

You can reach Biointaxis by e-mail at info@biointaxis.com.

AI-generated from reviews on this page. Verify anything important with the company directly.

Dhira Vaidya
Reviews 1

I appreciate the professionalism and dedication of the Biointaxis team. They have provided excellent services and solutions for our company. The results we have achieved are beyond our expectations. I highly recommend Biointaxis to any business looking for innovative solutions and outstanding support.

Kristen Burk
Reviews 1

🔥 Biointaxis is simply the best! The team is very professional and always goes the extra mile to meet our needs. We have been working with them for a while now and we are extremely satisfied with their services. They truly understand our requirements and deliver exceptional results. 🔥

Sheila Polite
Reviews 1

We are extremely pleased with the services provided by Biointaxis. Their solutions have helped us optimize our operations and improve productivity. The team is highly skilled and professional. We highly recommend Biointaxis to any company in need of innovative solutions.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Biointaxis

Spinout from the Igtp for neurodegenerative rare diseases.